.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Queensland Health
McKesson
Johnson and Johnson
Dow
Cantor Fitzgerald
Novartis
Boehringer Ingelheim
US Army

Generated: July 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.
Inventor(s): Hodge; Robert Emil (Thousand Oaks, CA), Webster; Jeffrey Douglas (Thousand Oaks, CA), Moriarty; Robert M. (Michiana Shores, IN)
Assignee: Kythera Biopharmaceuticals, Inc. (Calabasas, CA)
Application Number:13/207,337
Patent Claims: 1. A composition consisting of a salt of deoxycholic acid and a pharmaceutically acceptable excipient, wherein said composition contains 0.5%.+-.0.1% of said salt which, when dissolved in water, is maintained at a pH of about 8.1 to about 8.5 and, when so maintained, said composition does not form a precipitate, and wherein said composition does not comprise phosphatidylcholine.

2. A composition consisting of a salt of deoxycholic acid and a pharmaceutically acceptable excipient, wherein said composition contains 1%.+-.0.1% of said salt which, when dissolved in water, is maintained at a pH of about 8.1 to about 8.5 and, when so maintained, said composition does not form a precipitate, and wherein said composition does not comprise phosphatidylcholine.

3. The composition of claims 1 or 2, wherein said excipient is a solvent, a buffer, a preservative, a lyophilization aid, or any combination thereof.

4. The composition of claim 3, wherein said excipient is a solvent.

5. The composition of claim 4, wherein said solvent is sterile water.

6. The composition of claim 3, wherein said excipient is a preservative.

7. The composition of claim 6, wherein said preservative is benzyl alcohol.

8. The composition of claim 7, wherein said preservative is 0.9% benzyl alcohol.

9. The composition of claims 1 or 2, wherein said composition has a pH of about 8.3.

10. A composition consisting of: a sterile aqueous solution buffered to a pH of about 8.3; 0.5%.+-.0.1% w/v of sodium deoxycholate; about 0.9% w/v benzyl alcohol; and about 1% w/v of sodium chloride, wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

11. A composition consisting of: an aqueous solution buffered to a pH of about 8.3; 1%.+-.0.1% w/v of sodium deoxycholate; about 0.9% w/v benzyl alcohol; and about 1% w/v of sodium chloride, wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

12. The composition of claim 1 or 2, wherein said salt is an alkali metal salt.

13. The composition of claim 12, wherein said alkali metal salt is sodium.

14. A composition consisting of: a sterile aqueous solution buffered to a pH of about 8.3; 0.5%.+-.0.1% w/v of sodium deoxycholate; about 10 mM sodium phosphate; about 0.9% w/v benzyl alcohol; and about 75 mM of sodium chloride, wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.

15. A composition consisting of: a sterile aqueous solution buffered to a pH of about 8.3; 1%.+-.0.1% w/v of sodium deoxycholate; about 10 mM sodium phosphate; and about 0.86% w/v of sodium chloride, wherein the composition is stable against precipitation, and wherein said composition does not comprise phosphatidylcholine.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Novartis
Harvard Business School
Julphar
Fish and Richardson
Cerilliant
Cantor Fitzgerald
Boehringer Ingelheim
Deloitte
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot